NumerixS Investment Technologies’s Achillion Pharmaceuticals ACHN Stock Holding History

NumerixS Investment Technologies’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-7,796	Closed	-$29K	–	1441
2018 Q1	$29K	Sell	7,796 -35,300	-82%	-$116K	0.01%	901
2017 Q4	$124K	Buy	+43,096	New	+$157K	0.03%	616
2017 Q3	–	Sell	-27,383	Closed	-$126K	–	1432
2017 Q2	$126K	Sell	27,383 -49,400	-64%	-$199K	0.02%	777
2017 Q1	$323K	Buy	76,783 +38,983	+103%	+$162K	0.04%	559
2016 Q4	$156K	Buy	37,800 +900	+2%	+$4.78K	0.02%	753
2016 Q3	$299K	Buy	36,900 +34,600	+1,504%	+$294K	0.04%	545
2016 Q2	$18K	Buy	+2,300	New	+$19.7K	﹤0.01%	1048
2015 Q3	–	Sell	-39,500	Closed	-$350K	–	836
2015 Q2	$350K	Buy	+39,500	New	+$374K	0.05%	458

Other funds holding ACHN

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

NumerixS Investment Technologies's ACHN Position: Q2 2018 in Review

NumerixS Investment Technologies sold out of Achillion Pharmaceuticals (ACHN) in Q2 2018, closing a stake of 7,796 shares — an estimated $29K sold.

NumerixS Investment Technologies first reported a position in ACHN in Q2 2015 and held it in 8 quarters. The position peaked at $350K in Q2 2015. 124 funds tracked by Wall St. Rank hold ACHN as of Q2 2018.

NumerixS Investment Technologies reported no remaining Achillion Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
NumerixS Investment Technologies sold 7,796 Achillion Pharmaceuticals shares in Q2 2018, an estimated $29K.
NumerixS Investment Technologies first reported a position in Achillion Pharmaceuticals in Q2 2015 and held it in 8 quarters.
NumerixS Investment Technologies's Achillion Pharmaceuticals position peaked at $350K in Q2 2015.
124 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q2 2018.

Based on NumerixS Investment Technologies's 13F filing for Q2 2018, filed 10 Aug 2018.